CYTOM PART A 润色咨询

CYTOMETRY PART A

出版年份:2003 年文章数:1469 投稿命中率: 开通期刊会员,数据随心看

出版周期:Monthly 自引率:17.8% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=1099189, encodeId=0f67109918910, content=RUNNINGTITLE和TITLE的区别?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099190, encodeId=245f1099190dd, content=RUNINGTITLE的撰写方法?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=501446, encodeId=73b350144692, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享:对于流式细胞分析这块是十分的专业,提的意见都很细致,建议大家一定要严格照审稿意见修改,如不能修改或者重做的话,一定给出充分的,而且是非常专业的理由。另外感觉这个杂志对对照组和同型对照的抗体要求比较严格。我照着意见修改后很快接收。两个审稿人,感觉一个是纯搞流式的,提的意见全是围绕流式的,另一个就是我做的那个领域的专家了,总之审稿人找的很合理。小编特别认真负责,我在系统中点错了,发邮件告知,小编立即发来了邮件,还有截图告诉我怎么做,我拖了两天才弄,小编还发邮件问我搞定了没有,是否有什么困难,感觉非常的认真负责。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=482, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48d358792, createdName=yingtaoxiaoni, createdTime=Fri Feb 28 11:39:00 CST 2014, time=2014-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=500346, encodeId=4b86500346c0, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享:投的leukemia,没有那么多临床标本,并且是和蛋白质组学的交叉研究,总之后来投了两个五六分的杂志,都是外审意见褒贬不一的,折腾了很久最终被拒。。。无奈下投了这个杂志。投出去第三天就收到了主编来信,说研究内容很有吸引人,就是偏离了他们杂志的研究内容,希望我能加一些流式分析的实验内容。我就稍微加了一些,审稿人提了很多文章中的小意见,都是修改语言和补充试剂出处一类的,照着改了,半个月后接收,很快就挂到网上了。总的感觉是杂志社和编辑都很友好,投稿难度不是很大。还是希望这个杂志越办越好,IF越来越高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=329, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1ac591869, createdName=olivia999, createdTime=Wed Dec 25 16:04:00 CST 2013, time=2013-12-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=481324, encodeId=d34048132487, content=看涨哦,如果明天再升一升,有望突破3分, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=500, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=medwu, createdTime=Wed Jun 29 15:50:00 CST 2011, time=2011-06-29, status=1, ipAttribution=)]
    2021-12-29 msSSSSSD

    RUNNINGTITLE和TITLE的区别?

    1

    展开1条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=1099189, encodeId=0f67109918910, content=RUNNINGTITLE和TITLE的区别?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099190, encodeId=245f1099190dd, content=RUNINGTITLE的撰写方法?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=501446, encodeId=73b350144692, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享:对于流式细胞分析这块是十分的专业,提的意见都很细致,建议大家一定要严格照审稿意见修改,如不能修改或者重做的话,一定给出充分的,而且是非常专业的理由。另外感觉这个杂志对对照组和同型对照的抗体要求比较严格。我照着意见修改后很快接收。两个审稿人,感觉一个是纯搞流式的,提的意见全是围绕流式的,另一个就是我做的那个领域的专家了,总之审稿人找的很合理。小编特别认真负责,我在系统中点错了,发邮件告知,小编立即发来了邮件,还有截图告诉我怎么做,我拖了两天才弄,小编还发邮件问我搞定了没有,是否有什么困难,感觉非常的认真负责。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=482, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48d358792, createdName=yingtaoxiaoni, createdTime=Fri Feb 28 11:39:00 CST 2014, time=2014-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=500346, encodeId=4b86500346c0, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享:投的leukemia,没有那么多临床标本,并且是和蛋白质组学的交叉研究,总之后来投了两个五六分的杂志,都是外审意见褒贬不一的,折腾了很久最终被拒。。。无奈下投了这个杂志。投出去第三天就收到了主编来信,说研究内容很有吸引人,就是偏离了他们杂志的研究内容,希望我能加一些流式分析的实验内容。我就稍微加了一些,审稿人提了很多文章中的小意见,都是修改语言和补充试剂出处一类的,照着改了,半个月后接收,很快就挂到网上了。总的感觉是杂志社和编辑都很友好,投稿难度不是很大。还是希望这个杂志越办越好,IF越来越高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=329, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1ac591869, createdName=olivia999, createdTime=Wed Dec 25 16:04:00 CST 2013, time=2013-12-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=481324, encodeId=d34048132487, content=看涨哦,如果明天再升一升,有望突破3分, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=500, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=medwu, createdTime=Wed Jun 29 15:50:00 CST 2011, time=2011-06-29, status=1, ipAttribution=)]
    2021-12-27 msSSSSSD

    RUNINGTITLE的撰写方法?

    1

    展开1条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=1099189, encodeId=0f67109918910, content=RUNNINGTITLE和TITLE的区别?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099190, encodeId=245f1099190dd, content=RUNINGTITLE的撰写方法?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=501446, encodeId=73b350144692, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享:对于流式细胞分析这块是十分的专业,提的意见都很细致,建议大家一定要严格照审稿意见修改,如不能修改或者重做的话,一定给出充分的,而且是非常专业的理由。另外感觉这个杂志对对照组和同型对照的抗体要求比较严格。我照着意见修改后很快接收。两个审稿人,感觉一个是纯搞流式的,提的意见全是围绕流式的,另一个就是我做的那个领域的专家了,总之审稿人找的很合理。小编特别认真负责,我在系统中点错了,发邮件告知,小编立即发来了邮件,还有截图告诉我怎么做,我拖了两天才弄,小编还发邮件问我搞定了没有,是否有什么困难,感觉非常的认真负责。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=482, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48d358792, createdName=yingtaoxiaoni, createdTime=Fri Feb 28 11:39:00 CST 2014, time=2014-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=500346, encodeId=4b86500346c0, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享:投的leukemia,没有那么多临床标本,并且是和蛋白质组学的交叉研究,总之后来投了两个五六分的杂志,都是外审意见褒贬不一的,折腾了很久最终被拒。。。无奈下投了这个杂志。投出去第三天就收到了主编来信,说研究内容很有吸引人,就是偏离了他们杂志的研究内容,希望我能加一些流式分析的实验内容。我就稍微加了一些,审稿人提了很多文章中的小意见,都是修改语言和补充试剂出处一类的,照着改了,半个月后接收,很快就挂到网上了。总的感觉是杂志社和编辑都很友好,投稿难度不是很大。还是希望这个杂志越办越好,IF越来越高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=329, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1ac591869, createdName=olivia999, createdTime=Wed Dec 25 16:04:00 CST 2013, time=2013-12-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=481324, encodeId=d34048132487, content=看涨哦,如果明天再升一升,有望突破3分, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=500, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=medwu, createdTime=Wed Jun 29 15:50:00 CST 2011, time=2011-06-29, status=1, ipAttribution=)]
    2014-02-28 yingtaoxiaoni

    审稿速度:2.0 | 投稿命中率:25.0
    经验分享:对于流式细胞分析这块是十分的专业,提的意见都很细致,建议大家一定要严格照审稿意见修改,如不能修改或者重做的话,一定给出充分的,而且是非常专业的理由。另外感觉这个杂志对对照组和同型对照的抗体要求比较严格。我照着意见修改后很快接收。两个审稿人,感觉一个是纯搞流式的,提的意见全是围绕流式的,另一个就是我做的那个领域的专家了,总之审稿人找的很合理。小编特别认真负责,我在系统中点错了,发邮件告知,小编立即发来了邮件,还有截图告诉我怎么做,我拖了两天才弄,小编还发邮件问我搞定了没有,是否有什么困难,感觉非常的认真负责。

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1099189, encodeId=0f67109918910, content=RUNNINGTITLE和TITLE的区别?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099190, encodeId=245f1099190dd, content=RUNINGTITLE的撰写方法?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=501446, encodeId=73b350144692, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享:对于流式细胞分析这块是十分的专业,提的意见都很细致,建议大家一定要严格照审稿意见修改,如不能修改或者重做的话,一定给出充分的,而且是非常专业的理由。另外感觉这个杂志对对照组和同型对照的抗体要求比较严格。我照着意见修改后很快接收。两个审稿人,感觉一个是纯搞流式的,提的意见全是围绕流式的,另一个就是我做的那个领域的专家了,总之审稿人找的很合理。小编特别认真负责,我在系统中点错了,发邮件告知,小编立即发来了邮件,还有截图告诉我怎么做,我拖了两天才弄,小编还发邮件问我搞定了没有,是否有什么困难,感觉非常的认真负责。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=482, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48d358792, createdName=yingtaoxiaoni, createdTime=Fri Feb 28 11:39:00 CST 2014, time=2014-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=500346, encodeId=4b86500346c0, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享:投的leukemia,没有那么多临床标本,并且是和蛋白质组学的交叉研究,总之后来投了两个五六分的杂志,都是外审意见褒贬不一的,折腾了很久最终被拒。。。无奈下投了这个杂志。投出去第三天就收到了主编来信,说研究内容很有吸引人,就是偏离了他们杂志的研究内容,希望我能加一些流式分析的实验内容。我就稍微加了一些,审稿人提了很多文章中的小意见,都是修改语言和补充试剂出处一类的,照着改了,半个月后接收,很快就挂到网上了。总的感觉是杂志社和编辑都很友好,投稿难度不是很大。还是希望这个杂志越办越好,IF越来越高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=329, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1ac591869, createdName=olivia999, createdTime=Wed Dec 25 16:04:00 CST 2013, time=2013-12-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=481324, encodeId=d34048132487, content=看涨哦,如果明天再升一升,有望突破3分, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=500, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=medwu, createdTime=Wed Jun 29 15:50:00 CST 2011, time=2011-06-29, status=1, ipAttribution=)]
    2013-12-25 olivia999

    审稿速度:2.0 | 投稿命中率:25.0
    经验分享:投的leukemia,没有那么多临床标本,并且是和蛋白质组学的交叉研究,总之后来投了两个五六分的杂志,都是外审意见褒贬不一的,折腾了很久最终被拒。。。无奈下投了这个杂志。投出去第三天就收到了主编来信,说研究内容很有吸引人,就是偏离了他们杂志的研究内容,希望我能加一些流式分析的实验内容。我就稍微加了一些,审稿人提了很多文章中的小意见,都是修改语言和补充试剂出处一类的,照着改了,半个月后接收,很快就挂到网上了。总的感觉是杂志社和编辑都很友好,投稿难度不是很大。还是希望这个杂志越办越好,IF越来越高。

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1099189, encodeId=0f67109918910, content=RUNNINGTITLE和TITLE的区别?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099190, encodeId=245f1099190dd, content=RUNINGTITLE的撰写方法?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=501446, encodeId=73b350144692, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享:对于流式细胞分析这块是十分的专业,提的意见都很细致,建议大家一定要严格照审稿意见修改,如不能修改或者重做的话,一定给出充分的,而且是非常专业的理由。另外感觉这个杂志对对照组和同型对照的抗体要求比较严格。我照着意见修改后很快接收。两个审稿人,感觉一个是纯搞流式的,提的意见全是围绕流式的,另一个就是我做的那个领域的专家了,总之审稿人找的很合理。小编特别认真负责,我在系统中点错了,发邮件告知,小编立即发来了邮件,还有截图告诉我怎么做,我拖了两天才弄,小编还发邮件问我搞定了没有,是否有什么困难,感觉非常的认真负责。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=482, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48d358792, createdName=yingtaoxiaoni, createdTime=Fri Feb 28 11:39:00 CST 2014, time=2014-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=500346, encodeId=4b86500346c0, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享:投的leukemia,没有那么多临床标本,并且是和蛋白质组学的交叉研究,总之后来投了两个五六分的杂志,都是外审意见褒贬不一的,折腾了很久最终被拒。。。无奈下投了这个杂志。投出去第三天就收到了主编来信,说研究内容很有吸引人,就是偏离了他们杂志的研究内容,希望我能加一些流式分析的实验内容。我就稍微加了一些,审稿人提了很多文章中的小意见,都是修改语言和补充试剂出处一类的,照着改了,半个月后接收,很快就挂到网上了。总的感觉是杂志社和编辑都很友好,投稿难度不是很大。还是希望这个杂志越办越好,IF越来越高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=329, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1ac591869, createdName=olivia999, createdTime=Wed Dec 25 16:04:00 CST 2013, time=2013-12-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=481324, encodeId=d34048132487, content=看涨哦,如果明天再升一升,有望突破3分, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=500, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=medwu, createdTime=Wed Jun 29 15:50:00 CST 2011, time=2011-06-29, status=1, ipAttribution=)]
    2011-06-29 medwu

    看涨哦,如果明天再升一升,有望突破3分

    0

共8条页码: 1/1页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分